Effect of Probiotic on the Gut Microbiota of Healthy Volunteers - Trial NCT06103253
Access comprehensive clinical trial information for NCT06103253 through Pure Global AI's free database. This phase not specified trial is sponsored by Wecare Probiotics Co., Ltd. and is currently Completed. The study focuses on Healthy Adults. Target enrollment is 112 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Wecare Probiotics Co., Ltd.
Timeline & Enrollment
N/A
Apr 20, 2023
Jun 28, 2023
Primary Outcome
gut microbiota diversity
Summary
The goal of this placebo-controlled randomized trial is to test the effect of intervention
 with Bifidobacterium animalis subsp. lactis BLa80 on the composition of the gut microbiota of
 healthy volunteers. The main question it aims to answer is whether probiotic can effectively
 regulate intestinal flora. Participants will take a package of probiotics every day, and
 their weight was recorded once a week using a weight scale. Blood and stool tests were
 conducted before and after taking probiotics.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06103253
Non-Device Trial